Increased Cellular Death [PE] class drugs

2 results

  • besponsa - inotuzumab ozogamicin injection, powder, lyophilized, for solution

    (Inotuzumab Ozogamicin)
    Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
    Besponsa treats relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) in adults and pediatric patients aged 1 year and older.
    Medication Details
    Savings Programs
    1
    Drug Interactions

  • venclexta - venetoclax

    (Venetoclax)
    Abbvie Inc.
    Venclexta treats adult CLL or SLL patients, and newly diagnosed AML in adults 75+ or with comorbidities preventing intensive chemotherapy, used in combination with azacitidine, decitabine, or low-dose cytarabine.
    Medication Details
    Drug Interactions